These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
746 related articles for article (PubMed ID: 27520485)
1. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1. Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485 [TBL] [Abstract][Full Text] [Related]
2. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223 [TBL] [Abstract][Full Text] [Related]
3. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994 [TBL] [Abstract][Full Text] [Related]
4. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling. Wu X; Qi J; Bradner JE; Xiao G; Chen LF J Biol Chem; 2013 Dec; 288(50):36094-105. PubMed ID: 24189064 [TBL] [Abstract][Full Text] [Related]
5. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms. Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731 [TBL] [Abstract][Full Text] [Related]
6. Red Ginseng Oil Inhibits TPA-Induced Transformation of Skin Epidermal JB6 Cells. Truong VL; Kong AN; Jeong WS J Med Food; 2018 Apr; 21(4):380-389. PubMed ID: 29271701 [TBL] [Abstract][Full Text] [Related]
7. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725 [TBL] [Abstract][Full Text] [Related]
8. Bromodomain-containing protein 4 regulates a cascade of lipid-accumulation-related genes at the transcriptional level in the 3T3-L1 white adipocyte-like cell line. Mochizuki K; Yamada M; Inoue T; Hariya N; Kubota T; Goda T Eur J Pharmacol; 2020 Sep; 883():173351. PubMed ID: 32650006 [TBL] [Abstract][Full Text] [Related]
10. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states. Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437 [TBL] [Abstract][Full Text] [Related]
11. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. Wollebo HS; Bellizzi A; Cossari DH; Salkind J; Safak M; White MK J Neurovirol; 2016 Oct; 22(5):615-625. PubMed ID: 27007123 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Li JJ; Westergaard C; Ghosh P; Colburn NH Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030 [TBL] [Abstract][Full Text] [Related]
13. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Lockwood WW; Zejnullahu K; Bradner JE; Varmus H Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19408-13. PubMed ID: 23129625 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Nomura M; Ma W; Chen N; Bode AM; Dong Z Carcinogenesis; 2000 Oct; 21(10):1885-90. PubMed ID: 11023547 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Rathert P; Roth M; Neumann T; Muerdter F; Roe JS; Muhar M; Deswal S; Cerny-Reiterer S; Peter B; Jude J; Hoffmann T; Boryń ŁM; Axelsson E; Schweifer N; Tontsch-Grunt U; Dow LE; Gianni D; Pearson M; Valent P; Stark A; Kraut N; Vakoc CR; Zuber J Nature; 2015 Sep; 525(7570):543-547. PubMed ID: 26367798 [TBL] [Abstract][Full Text] [Related]
17. Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K. Lee JH; Kim JE; Jang YJ; Lee CC; Lim TG; Jung SK; Lee E; Lim SS; Heo YS; Seo SG; Son JE; Kim JR; Lee CY; Lee HJ; Lee KW Mol Carcinog; 2016 May; 55(5):552-62. PubMed ID: 25787879 [TBL] [Abstract][Full Text] [Related]
18. BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells. Li J; Ma J; Meng G; Lin H; Wu S; Wang J; Luo J; Xu X; Tough D; Lindon M; Rioja I; Zhao J; Mei H; Prinjha R; Zhong Z Stem Cell Res; 2016 Sep; 17(2):212-221. PubMed ID: 27591477 [TBL] [Abstract][Full Text] [Related]
19. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262 [TBL] [Abstract][Full Text] [Related]
20. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1. Horne GA; Stewart HJ; Dickson J; Knapp S; Ramsahoye B; Chevassut T Stem Cells Dev; 2015 Apr; 24(7):879-91. PubMed ID: 25393219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]